Literature DB >> 22271078

Role of IVC filters in endovenous therapy for deep venous thrombosis: the FILTER-PEVI (filter implantation to lower thromboembolic risk in percutaneous endovenous intervention) trial.

Mohsen Sharifi1, Curt Bay, Laura Skrocki, David Lawson, Shahnaz Mazdeh.   

Abstract

OBJECTIVES: The purpose of this study was to evaluate the necessity of and recommend indications for inferior vena cava (IVC) filter implantation during percutaneous endovenous intervention (PEVI) for deep venous thrombosis (DVT).
BACKGROUND: PEVI has emerged as a powerful tool in the management of acute proximal DVT. Instrumentation of extensive fresh thrombus is potentially associated with iatrogenic pulmonary embolism (PE). The true frequency of this complication has not been studied in a randomized fashion. We evaluated IVC filter implantation during PEVI for DVT.
METHODS: A total of 141 patients with symptomatic proximal DVT undergoing PEVI for symptomatic DVT were randomized to receive an IVC filter (70 patients) or no filter (71 patients; control group). The anticoagulation and PEVI regimen were similar between the two groups. Patients with development of symptoms suggestive of PE underwent objective testing for PE.
RESULTS: PE developed in 1 of the 14 symptomatic patients in the filter group and 8 of the 22 patients in the control group (P = 0.048). There was no mortality in any group. Three patients (4.2%) in the control group had transient hemodynamic instability necessitating resuscitory efforts. Predictors of iatrogenic PE were found to be PE at admission; involvement of two or more adjacent venous segments with acute thrombus; inflammatory form of DVT (severe erythema, edema, pain, and induration); and vein diameter of ≥7 mm with preserved architecture.
CONCLUSIONS: IVC filter implantation during PEVI reduces the risk of iatrogenic PE by eightfold without a mortality benefit. A selective approach may be exercised in filter implantation during PEVI.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22271078     DOI: 10.1007/s00270-012-0342-z

Source DB:  PubMed          Journal:  Cardiovasc Intervent Radiol        ISSN: 0174-1551            Impact factor:   2.740


  13 in total

Review 1.  Are too many inferior vena cava filters used? Controversial evidences in different clinical settings: a narrative review.

Authors:  Michele Dalla Vestra; Elisabetta Grolla; Luca Bonanni; Raffaele Pesavento
Journal:  Intern Emerg Med       Date:  2016-11-21       Impact factor: 3.397

2.  Systematic review of efficacy and safety of retrievable inferior vena caval filters.

Authors:  Behnood Bikdeli; David Jiménez; Ajay J Kirtane; Michael B Bracken; Frederick A Spencer; Manuel Monreal; Harlan M Krumholz
Journal:  Thromb Res       Date:  2018-03-17       Impact factor: 3.944

Review 3.  Inferior vena cava filter use and patient safety: legacy or science?

Authors:  William Geerts; Rita Selby
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2017-12-08

4.  Inferior vena cava filter insertion through the popliteal vein: enabling the percutaneous endovenous intervention of deep vein thrombosis with a single venous access approach in a single session.

Authors:  Hyoung Ook Kim; Jae Kyu Kim; Jin Gyoon Park; Nam Yeol Yim; Yang Jun Kang; Hye Doo Jung
Journal:  Diagn Interv Radiol       Date:  2016 Sep-Oct       Impact factor: 2.630

5.  Percutaneous endovenous intervention without vena cava filter for acute proximal deep vein thrombosis secondary to iliac vein compression syndrome: preliminary outcomes.

Authors:  Qiaohua Zhu; Dehua Chen; Chengyu Zhou; Meihua Luo; Wei Huang; Jiangyuan Huang; Junyong Huang; Yong Chen
Journal:  Radiol Med       Date:  2021-01-04       Impact factor: 3.469

Review 6.  Inferior vena cava filters: a framework for evidence-based use.

Authors:  Amar H Kelkar; Anita Rajasekhar
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2020-12-04

7.  [Vena cava filter. Which indications remain in the era of differentiated anticoagulation?].

Authors:  A H Mahnken
Journal:  Radiologe       Date:  2013-03       Impact factor: 0.635

8.  Effect of rivaroxaban on preventing deep vein thrombosis in aged diabetics with femoral neck fractures after hip replacement.

Authors:  Yi-Min Zhang; Xin Jiang; Yan-Shan Sun
Journal:  Biosci Rep       Date:  2017-06-21       Impact factor: 3.840

Review 9.  Diagnosis and Treatment of Lower Extremity Deep Vein Thrombosis: Korean Practice Guidelines.

Authors:  Seung-Kee Min; Young Hwan Kim; Jin Hyun Joh; Jin Mo Kang; Ui Jun Park; Hyung-Kee Kim; Jeong-Hwan Chang; Sang Jun Park; Jang Yong Kim; Jae Ik Bae; Sun Young Choi; Chang Won Kim; Sung Il Park; Nam Yeol Yim; Yong Sun Jeon; Hyun-Ki Yoon; Ki Hyuk Park
Journal:  Vasc Specialist Int       Date:  2016-09-30

10.  Vena caval filters for the prevention of pulmonary embolism.

Authors:  Tim Young; Krishna Bajee Sriram
Journal:  Cochrane Database Syst Rev       Date:  2020-10-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.